ZA972909B - Detecting genetic predisposition for osteoporosis - Google Patents

Detecting genetic predisposition for osteoporosis

Info

Publication number
ZA972909B
ZA972909B ZA972909A ZA972909A ZA972909B ZA 972909 B ZA972909 B ZA 972909B ZA 972909 A ZA972909 A ZA 972909A ZA 972909 A ZA972909 A ZA 972909A ZA 972909 B ZA972909 B ZA 972909B
Authority
ZA
South Africa
Prior art keywords
osteoporosis
genetic predisposition
detecting genetic
genomic dna
methods
Prior art date
Application number
ZA972909A
Other languages
English (en)
Inventor
Gordon W Duff
Graham Russell
Richard Eastell
Original Assignee
Medical Science Sys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Science Sys Inc filed Critical Medical Science Sys Inc
Publication of ZA972909B publication Critical patent/ZA972909B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA972909A 1996-04-05 1997-04-04 Detecting genetic predisposition for osteoporosis ZA972909B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/628,282 US5698399A (en) 1996-04-05 1996-04-05 Detecting genetic predisposition for osteoporosis

Publications (1)

Publication Number Publication Date
ZA972909B true ZA972909B (en) 1998-10-26

Family

ID=24518226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA972909A ZA972909B (en) 1996-04-05 1997-04-04 Detecting genetic predisposition for osteoporosis

Country Status (13)

Country Link
US (1) US5698399A (de)
EP (1) EP0832298B1 (de)
CN (1) CN100347313C (de)
AT (1) ATE247718T1 (de)
AU (1) AU712461B2 (de)
CA (1) CA2226223C (de)
DE (1) DE69724209T2 (de)
ES (1) ES2208892T3 (de)
IL (1) IL122808A (de)
MX (1) MX9800192A (de)
NZ (1) NZ329530A (de)
WO (1) WO1997038135A1 (de)
ZA (1) ZA972909B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU723751B2 (en) * 1996-01-17 2000-09-07 Sequenom-Gemini Limited Diagnostic method and apparatus
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
GB9621129D0 (en) 1996-10-10 1996-11-27 Duff Gordon W Detecting genetic predisposition to sight-threatening diabetic retinopathy
US7820383B2 (en) * 1997-03-10 2010-10-26 Interleukin Genetics, Inc. Method for diagnosing myocardial infarction
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
US6524795B1 (en) * 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
GB9706359D0 (en) * 1997-03-27 1997-05-14 Gemini International Holdings Polymorphisms of an il-1 receptor antagonist gene
JP2002503956A (ja) * 1997-04-23 2002-02-05 アボツト・ラボラトリーズ 前立腺の疾患の検出に有用な試薬および方法
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050282198A1 (en) * 1997-05-29 2005-12-22 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
EP1071822A2 (de) * 1998-04-21 2001-01-31 Interleukin Genetics, Inc. Foetales untersuchungsverfahren zur vorhersage von geringem geburtsgewicht
WO1999066077A2 (en) * 1998-06-16 1999-12-23 Exact Laboratories, Inc. Methods for the detection of nucleic acids
AUPP547398A0 (en) * 1998-08-26 1998-09-17 Medvet Science Pty. Ltd. Predictive assessment of certain skeletal disorders
CA2343049A1 (en) * 1998-09-15 2000-03-23 Signalgene Inc. Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose a response to osteoporosis therapy
AU2587500A (en) * 1998-11-30 2000-06-19 Drexel University Methods and kits for identifying individuals at risk of developing osteoporosis
US6762023B1 (en) 1998-11-30 2004-07-13 Drexel University Methods for identifying individuals at risk of developing osteoporosis
CA2378221A1 (en) * 1999-06-30 2001-01-04 Interleukin Genetics, Inc. Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
EP1212464B1 (de) * 1999-08-30 2006-02-22 Interleukin Genetics, Inc. Diagnostika und therapeutika für osteoporose
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
WO2001078575A2 (en) * 2000-04-17 2001-10-25 Oregon Health & Science University Ext2 as a predictive marker for osteoporosis
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
CA2450809A1 (en) * 2001-06-15 2002-12-27 Interleukin Genetics, Inc. Methods for detecting and treating the early onset of aging-related conditions
GB2381526A (en) * 2001-11-03 2003-05-07 Sequenom Inc Detection of predisposition to osteoporosis
JP4492849B2 (ja) * 2001-11-19 2010-06-30 インターリューキン ジェネティックス インコーポレイテッド 転写および炎症性疾患および感染症に対する感受性に影響するインターロイキン−１遺伝子座の機能的多型
US20080311581A1 (en) * 2001-11-19 2008-12-18 David Wyllie Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
US20030148288A1 (en) * 2002-02-01 2003-08-07 Yi-Wei Tang Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
US20030198316A1 (en) * 2002-04-17 2003-10-23 Piet Dewaele Osteoporosis screening method
US20040229228A1 (en) * 2002-07-25 2004-11-18 Northwestern University Il-1 genotype in early kidney allograft rejection
ATE389034T1 (de) * 2002-09-30 2008-03-15 Novartis Pharma Gmbh Verfahren zur voraussage der erhöhung von cholesterin während einer immunosuppresiven therapie
GB0301715D0 (en) * 2003-01-24 2003-02-26 King S College London Detection of predisposition to osteoporosis
ATE490339T1 (de) * 2003-08-08 2010-12-15 Interleukin Genetics Inc Diagnostikum für osteoporose
US20090170105A1 (en) * 2007-11-08 2009-07-02 Interleukin Genetics, Inc. Diagnostics for Aging-Related Dermatologic Disorders
AU2009242490B2 (en) 2008-05-02 2015-01-22 Orig3N, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
US20100129798A1 (en) * 2008-05-02 2010-05-27 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3536853A1 (de) 2018-03-06 2019-09-11 Lenzing Aktiengesellschaft Lyocellfaser mit verringerter pillenbildung
EP3980561A1 (de) 2019-06-06 2022-04-13 Sitokine Limited Zusammensetzungen und verfahren zur behandlung von lungen-, kolorektal- und brustkrebs
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
DE69333659T2 (de) * 1992-07-31 2005-11-17 Garvan Institute Of Medical Research, Darlinghurst Einschätzung von in trans-agierenden faktoren der allelen variation
IT1269989B (it) * 1994-09-21 1997-04-16 Dompe Spa Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria

Also Published As

Publication number Publication date
ES2208892T3 (es) 2004-06-16
EP0832298B1 (de) 2003-08-20
EP0832298A1 (de) 1998-04-01
WO1997038135A1 (en) 1997-10-16
DE69724209T2 (de) 2004-06-17
MX9800192A (es) 1998-11-30
US5698399A (en) 1997-12-16
CN100347313C (zh) 2007-11-07
DE69724209D1 (de) 2003-09-25
AU2607797A (en) 1997-10-29
CN1194668A (zh) 1998-09-30
IL122808A (en) 2000-08-31
NZ329530A (en) 1999-10-28
IL122808A0 (en) 1998-08-16
EP0832298A4 (de) 1999-09-08
AU712461B2 (en) 1999-11-04
CA2226223C (en) 2001-11-20
ATE247718T1 (de) 2003-09-15
CA2226223A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
ZA972909B (en) Detecting genetic predisposition for osteoporosis
Wylie et al. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation
GB9704054D0 (en) Assay
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
Moutou et al. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic
CA2300355A1 (en) Detection of genetic alterations of chromosome 20q that are associated with breast cancer
AU8132194A (en) Single nucleotide polymorphisms and their use in genetic analysis
WO2003012046A3 (en) Stk15 (stk6) gene polymorphism and methods of determining cancer risk
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
IL129390A0 (en) Method and kit for detecting genetic predisposition to slight-threatening diabetic retinopathy
IL132099A0 (en) Methods for assessing cardiovascular status and compositions for use therein
WO1997043446A3 (en) Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an il-6 gene
DE69938837D1 (de) Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
WO1997024974A3 (en) Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene
WO2003022875A3 (en) Polymorphisms of pd-1
WO1999066077A3 (en) Methods for the detection of nucleic acids
WO1999002736A3 (en) Sr-bi nucleic acids and uses therefor
EP0920538A4 (de) Verfahren zur diganose und feststellung der prädisposition von bipolaren gemütserkrankungen
WO2003066903A3 (en) Genetic markers for bone mass
WO1997032998A3 (en) Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
WO2000042216A3 (en) Genetic predisposition to abnormal calcification conditions
TWI266805B (en) Method of detecting genetic disorders
ES2104478T3 (es) Metodos de identificar linfocitos con fenotipos mutadores.
WO2001074833A3 (en) Haplotypes of the chrnb2 gene
GB9726804D0 (en) Mood disorder gene